Literature DB >> 7857364

Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition.

B J Gaynor1, T Sand, R W Clark, R J Aiello, M J Bamberger, J B Moberly.   

Abstract

We investigated the role of cholesteryl ester transfer protein (CETP) in hamsters by using a monoclonal antibody (MAb) that inhibited hamster CETP activity. MAbs were prepared against partially purified human CETP and screened for inhibiton of 3H-cholesteryl oleate (CE) transfer from LDL to HDL in the presence of human plasma bottom fraction (d > 1.21 g/ml). Antibody 1C4 inhibited CE transfer activity in both human plasma bottom fraction (IC50 = approximately 4 micrograms/ml) and in whole plasma from male Golden Syrian hamsters (IC50 = approximately 30 micrograms/ml). Purified MAb 1C4 was injected into chow- and cholesterol-fed hamsters, and blood was collected for analysis of plasma CETP activity and HDL lipid composition. Plasma CETP activity was inhibited by 70%-80% at all and HDL lipid composition. Plasma CETP activity was inhibited by 70%-80% at all times up to 24 h following injection of 500 micrograms MAb 1C4 (approximately 3.7 mg/kg). The amount of antibody required for 50% inhibition at 24 h post-injection was 200 micrograms (approximately 1.5 mg/kg). Inhibition of hamster CETP activity in vivo increased hamster HDL cholesterol by 33% (P < 0.0001), increased HDL-CE by 31% (P < 0.0001) and decreased HDL-triglyceride by 42% (P < 0.0001) (n = 36) as determined following isolation of HDL by ultracentrifugation. An increase in HDL cholesterol and a redistribution of cholesterol to a larger HDL particle were also observed following fast protein liquid chromatography (FPLC) gel filtration of plasma lipoproteins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857364     DOI: 10.1016/0021-9150(94)90073-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary.

Authors:  Dhruv Kazi; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

2.  Anacetrapib-driven triglyceride lowering explained: the fortuitous role of CETP in the intravascular catabolism of triglyceride-rich lipoproteins.

Authors:  Amanda L Brown; J Mark Brown
Journal:  J Lipid Res       Date:  2017-04-21       Impact factor: 5.922

3.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

4.  Blood Lipid Distribution, Aortic Cholesterol Concentrations, and Selected Inflammatory and Bile Metabolism Markers in Syrian Hamsters Fed a Standard Breeding Diet.

Authors:  Amanda M Stephens; Timothy H Sanders
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-07       Impact factor: 1.232

Review 5.  Cholesteryl ester transfer protein and its inhibitors.

Authors:  Sudichhya Shrestha; Ben J Wu; Liam Guiney; Philip J Barter; Kerry-Anne Rye
Journal:  J Lipid Res       Date:  2018-02-27       Impact factor: 5.922

6.  Interaction of CETP inhibitory peptide and lipoprotein substrates in cholesteryl ester transfer assay: relationship between association properties and inhibitory activities.

Authors:  Kyung-Hyun Cho; Ju-Young Lee; Myung-Sook Choi; Song-Hae Bok; Yong Bok Park
Journal:  Lipids       Date:  2002-07       Impact factor: 1.880

Review 7.  Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.

Authors:  Hiroshi Mabuchi; Atsushi Nohara; Akihiro Inazu
Journal:  Mol Cells       Date:  2014-11-06       Impact factor: 5.034

8.  High Fat-High Fructose Diet-Induced Changes in the Gut Microbiota Associated with Dyslipidemia in Syrian Hamsters.

Authors:  Rachael G Horne; Yijing Yu; Rianna Zhang; Nyan Abdalqadir; Laura Rossi; Michael Surette; Philip M Sherman; Khosrow Adeli
Journal:  Nutrients       Date:  2020-11-20       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.